Agne Paner, MD, director, discusses the phase II HORIZON trial in relapsed/refractory multiple myeloma.
Agne Paner, MD
Advertisement
Articles by Agne Paner, MD
Advertisement
Latest Updated Articles
Dr. Paner on HORIZON Trial in Multiple MyelomaJanuary 29th 2020
Advertisement
Advertisement
Trending on OncLive
1
Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg
2
HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA
3
Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL
4
Dato-DXd Hits Key Secondary Efficacy End Points in First-Line TNBC
5